Omda Medication Management Solutions and Safe, Secure Healthcare Delivery

Omda Medication Management Solutions and Safe, Agile and Secure Healthcare Delivery

Traditionally, cancer treatment required multiple teams to coordinate complex care using inadequate tools. While elements of medication management and care provision are digitalised, there is still a heavy reliance on paper-based processes and printouts, particularly when communicating decisions and information between teams. In many cases, medication prescriptions are printed and then faxed to the pharmacy for production.

Such an approach is inefficient, slow and susceptible to error. In a busy and testing work environment, in which critical decisions are made, mistakes and inefficiencies can mean the difference between life and death. It is incredibly difficult to deliver high-quality care without a digital medical oncology solution that contains all the relevant information about a patient’s treatment and helps coordinate care. Handovers between healthcare professionals and teams are confusing, while transferring patients from one hospital to another for specialist treatment is challenging to manage, as patient data is inaccessible or goes missing. 

Pressing healthcare challenges just like these will be the focus of the 2024 E-Health in Norway (EHiN) conference. Running from the 12th to the 13th of November, it is an opportunity to explore the key issues facing healthcare systems in Norway, the Nordics and further afield. It is also a chance to showcase the digital solutions that will help us overcome them. In the context of complex and often inefficient cancer treatment processes, that solution is our groundbreaking medication management platform, Omda Cytodose. 

Connecting medication management for safer treatment

In today’s remarkably complex healthcare landscape, where diverse teams and specialists collaborate to deliver cutting-edge care, Omda Cytodose supports treatments for all forms of cancer and enables transparent interaction between contributing health professionals.

By providing a comprehensive overview of a patient’s treatment and connecting various teams and departments, Omda Cytodose facilitates safer, more efficient care and coordinated treatment. All information is entered into a centralised system, ensuring seamless handovers between healthcare professionals and empowering clinical decision-makers by providing access to all available data. This also translates to greater transparency and improved oversight.

Support for FMD 2D barcode scanning, standardised protocols, built-in dose calculations, and integrated checks and balances to prevent erroneous data entries both streamline workflows and improve patient safety. The web-based pharmacy module connects clinicians and pharmacists directly and facilitates safe and customised medication production. Crucially, it does so while creating a detailed account of actions taken and eliminating the scope for human error. In turn, this direct link with the pharmacy enabled various new developments, including robotic automation of medication production and the introduction of AI technologies to ensure correct dosing.

A proven success and the future of medication management

The recent announcement that the South-Eastern Norway Regional Health Authority has opted to introduce the solution demonstrates its success. The Omda Cytodose solution is now employed by regional health authorities serving 90% of the Norwegian population. The move cements Omda’s position as the Nordics’ leading oncology medication management software provider. It also illustrates the power of innovative e-health oncology technology to facilitate agile, safe and secure healthcare delivery and change patшents’ lives in the process.

Omda Oncology at EHiN 2024

On the 12th and the 13th of November, 2024, the Omda Medication Management team will showcase the Omda Cytodose solution at the EHiN conference. The team will be based at Stand C1 and is more than happy to spend time discussing the solution and how it can deliver value for your organisation and facilitate safer, more effective oncology treatment. If you’d like to prearrange a meeting, please get in touch via the contact details below or click here to see the EHiN info page.

Helen Døcker
Chief Marketing and Communications Officer
Categories

Related News

Deploying Agile Healthcare Solutions in Blood Management
Read More
Ageing Populations and the Importance of Connected Healthcare
Read More
Omda Medication Management Solutions and Safe, Secure Healthcare Delivery
Read More
Empowering Patients at Home and Beyond with Omda Wellme
Read More

Get in touch

Please enable JavaScript in your browser to complete this form.
Name
Helen Døcker
Chief Marketing & Communications Officer
helen.docker@omda.com
She is based in the company’s headquarters in Oslo, Norway.

Join our conversation to build a safer and healthier world.